What we do Achyut Healthcare Ltd trades customized pharmaceutical products like immunosuppressants and vitamins domestically and internationally. |
Founded in 1,996 |
Market share Established pan-India and international presence in pharmaceutical trading, serving India, UAE, Kenya, and Nigeria. |
Problem solved Provides tailored pharmaceutical solutions meeting diverse client needs through quality and customized products. |
Top clients or who we serve Serves distributors, merchants, exporters, and end users in B2B and B2C segments. |
Key management Mr. Jigen J. Modi (Managing Director), Mr. Mahendra C. Raycha (Chairman), Mrs. Amisha J. Modi (Director). |
Our journey and innovations Incorporated in 1996; public listing in 2022; expanding into manufacturing from 2026 to diversify business. |
Where we operate India, UAE, Kenya, Nigeria, with pan-India coverage. |
Top products or what we offer Cenzure, Arpimune, Everolimus, Tacrolimus, infrared thermometers, vitamins, and pharmaceutical intermediates. |
Top brands - |
Raw materials needed Pharmaceutical raw materials for manufacturing tablets, capsules, and other dosage forms planned. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue primarily from trading sales, transitioning to manufacturing for stable recurring income. |
Our industry position Growing SME-listed pharmaceutical trader aiming to migrate to BSE main board. |
Financial highlights FY25 revenue Rs. 3.05 crore, net profit Rs. 0.55 crore; past growth includes raised IPO Rs. 3.6 crore. |
Geographical revenue split Revenue from India and exports to UAE, Kenya, Nigeria. |
Order book - |
Whats driving growth Expansion into pharma manufacturing, strong distribution network, and international markets. |
Our future plans Launching manufacturing plants for tablets, capsules, and other pharmaceuticals by 2026. |
Our green promise - |
Our people and values Focus on professional team managing procurement, marketing, sales, and delivery with governance. |
Key challenges ahead Commodity price volatility, regulatory risks, HR retention, and scaling manufacturing. |
Interesting facts Listed on BSE SME in 2022; plans to move to main board after meeting criteria. |
Risks and strategy Proactively managing price, regulation, and strategic risks with internal audits and compliance. |
